Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations
Open Access
- 11 September 2020
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 98 (11) , 1603-1613
Abstract
The predictive value of traditional cardiovascular risk estimators is limited, and young and elderly populations are particularly underrepresented. We aimed to investigate the urine metabolome and its association with cardiovascular risk to identify novel markers that might complement current estimators based on age. Urine samples were collected from 234 subjects categorized into three age-grouped cohorts: 30–50 years (cohort I, young), 50–70 years (cohort II, middle-aged), and > 70 years (cohort III, elderly). Each cohort was further classified into three groups: (a) control, (b) individuals with cardiovascular risk factors, and (c) those who had a previous cardiovascular event. Novel urinary metabolites linked to cardiovascular risk were identified by nuclear magnetic resonance in cohort I and then evaluated by target mass spectrometry quantification in all cohorts. A previously identified metabolic fingerprint associated with atherosclerosis was also analyzed and its potential risk estimation investigated in the three aged cohorts. Three different metabolic signatures were identified according to age: 2-hydroxybutyrate, gamma-aminobutyric acid, hypoxanthine, guanidoacetate, oxaloacetate, and serine in young adults; citrate, cyclohexanol, glutamine, lysine, pantothenate, pipecolate, threonine, and tyramine shared by middle-aged and elderly adults; and trimethylamine N-oxide and glucuronate associated with cardiovascular risk in all three cohorts. The urinary metabolome contains a metabolic signature of cardiovascular risk that differs across age groups. These signatures might serve to complement existing algorithms and improve the accuracy of cardiovascular risk prediction for personalized prevention. Key messages: • Cardiovascular risk in the young and elderly is underestimated. • The urinary metabolome reflects cardiovascular risk across all age groups. • Six metabolites constitute a metabolic signature of cardiovascular risk in young adults. • Middle-aged and elderly adults share a cardiovascular risk metabolic signature. • TMAO and glucuronate levels reflect cardiovascular risk across all age groups.Keywords
Funding Information
- ISCIII (PI14/01650, PI14/01917, PI14/01841, PI16/01334, IF08/3667-1, FI12/00126, CPII15/00027, CP15/00129, PT13/0001/0013, PI17/01093, PI17/01193, PI18/00995, Grant PRB3 (IPT17/0019 ISCIIIS-GEFI/ERDF))
- REDINREN (RD12/0021/0001, RD16/0009)
- Sociedad Española de Cardiología para la Investigación Básica 2017
- Fundación Senefro
- Fundación Renal Iñigo Alvarez de Toledo
- Fundación Conchita Rábago
This publication has 52 references indexed in Scilit:
- Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early preventionAtherosclerosis, 2019
- Urinary metabonomic study of patients with acute coronary syndrome using UPLC-QTOF/MSJournal of Chromatography B, 2018
- Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic ReviewJournal of the American Heart Association, 2017
- Trimethylamine N-oxide and Risk Stratification after Acute Myocardial InfarctionClinical Chemistry, 2017
- Regulation of uric acid metabolism and excretionInternational Journal of Cardiology, 2016
- Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged CohortCirculation, 2015
- Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: From bench to point-of-careExperimental Biology and Medicine, 2015
- KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recoveryMetabolomics, 2014
- Inhibitory role for GABA in atherosclerosisMedical Hypotheses, 2013
- From Vulnerable Plaque to Vulnerable PatientCirculation, 2003